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Abstract
Background: To ascertain the impact of postpartum onset (PPO) on the subsequent time course
of mood disorders.
Methods: This retrospective study compared per year rates of excited (manic or mixed) and
depressive episodes between fifty-five women with bipolar (N = 22) or major depressive (N = 33)
disorders with first episode occurring postpartum (within four weeks after childbirth according to
DSM-IV definition) and 218 non-postpartum onset (NPPO) controls. Such patients had a traceable
illness course consisting of one or more episodes alternating with complete symptom remission
and no additional diagnoses of axis I disorders, mental retardation or brain organic diseases. A
number of variables reported to influence the course of mood disorders were controlled for as
possible confounding factors
Results: Bipolar women with postpartum onset disorder had fewer excited episodes (p = 0.005)
and fewer episodes of both polarities (p = 0.005) compared to non-postpartum onset subjects. No
differences emerged in the rates of depressive episodes. All patients who met criteria for rapid
cycling bipolar disorder (7 out of 123) were in the NPPO group. Among major depressives, PPO
patients experienced fewer episodes (p = 0.016). With respect to clinical and treatment features,
PPO-MDD subjects had less personality disorder comorbidity (p = 0.023) and were less likely to
be on maintenance treatment compared to NPPO comparison subjects (p = 0.002)
Conclusion: Such preliminary findings suggest that PPO mood disorders may be characterized by
a less recurrent time course. Future research in this field should elucidate the role of comorbid
personality disorders and treatment. Moreover it should clarify whether PPO disorders are also
associated with a more positive outcome in terms of social functioning and quality of life.
Background
The lifetime time course of mood disorders ranges from a
single episode of illness to a recurrent pattern with few or
no intervals [1]. This heterogeneity would suggest abun-
dance of course predictors. To date, however, despite con-
siderable efforts by several research groups, only a few of
them have been identified. The strongest prognostic factor
is the number of previous affective episodes [2,3]. There is
mounting evidence that cycle length gets progressively
shorter within the first three to five episodes, then it
approaches a level corresponding to the maximum indi-
vidual frequency of episodes [3]. Therefore episode
number is a late predictor. On the contrary it would be
desirable to influence illness process before it comes to its
peak. This necessarily leads to search early predictors,
most of which should be related to the first episode.
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Amongst such variables polarity has probably been inves-
tigated the most: a number of studies have consistently
demonstrated that bipolar disorders with manic or mixed
onset are associated with a worse outcome than depres-
sive onset forms, although such a difference seems to dis-
appear with illness duration [4-6].
The role of age at onset is more controversial: some
authors have indicated a worse prognosis for early onset
patients [7] but others failed to confirm this finding [8] or
even reported an association in the opposite direction [9]
The presence of psychotic symptoms has also been associ-
ated with a higher rate of relapse and a rapid deteriorating
course [10-13], along with other descriptors such as fam-
ily history of psychiatric illness [14], comorbidity with
anxiety or personality disorders [15] and substance abuse
[16].
The aim of this study was to assess the influence of post-
partum onset on mood disorder course.
Methods
Subjects
This retrospective study is based on the data of a large
population of women consecutively admitted to the
Center for Mood Disorders of S. Raffaele Hospital (HSR-
CMD) in Milan during the period between January 1990
and January 2000. These subjects have participated in pre-
vious genetic and clinical trials undertaken by our
research group [17-21] and we remand to those publica-
tions for a thorough description of their recruitment.
Informed consent was obtained after the procedure was
explained to subjects and studies were performed after
approval of the local ethical committee.
Eligible subjects were bipolar I and major depressive
women aged between 15 and 44 years at illness onset who
had a traceable illness course characterized by one or
more affective episodes alternating with complete remis-
sion defined as a HDRS17 score <7 [22] and no symptoms
of DSM-IV hypomanic, manic or mixed episodes [23].
Their minimum length of illness was 1 year calculated
from the onset of the intake episode to study entry. Rapid
cycling, the occurrence of ≥ 4 episodes within one year
[24], was not considered among exclusion criteria. Instead
additional diagnoses of mental retardation, substance-
related disorders or other Axis I disorders and the presence
of any organic disease impairing psychiatric evaluation
were considered exclusion criteria. Moreover we excluded
all patients without reliable treatment histories.
1,080 women charts were reviewed to be included in the
study, of whom 125 had their first episode during the
postpartum period (within 4 weeks after childbirth
according to DSM IV definition) [23]. By applying the
selection criteria mentioned above the study sample was
reduced to 55 women with postpartum onset (PPO)
mood disorders and 218 non-postpartum onset (NPPO)
controls. These subjects did not significantly differ from
the original population as for age, diagnostic subtype (BP
vs MDD) and familiarity.
Diagnostic assessment and data collection
Lifetime diagnoses were assigned by two independent
psychiatrists according to DSM-III-R and DSM-IV criteria
[23,25] on the basis of structural clinical interviews –
SCID version 1.0 [26], SCID-I/P version 2.0 [27] and
SCID II for personality disorders [28] – and complemen-
tary information gathered from the patients' relatives,
other health professionals and, when available, medical
records [29]. The treating psychiatrist proposed prelimi-
nary diagnoses of Axis I and Axis II disorders which had to
be confirmed by a senior psychiatrist blind to his col-
league's evaluation. If there was no agreement, a second
senior psychiatrist was involved. If disagreement per-
sisted, the case was ruled out. Actually no patient was
excluded because of discordant classification.
A similar consensus procedure was employed to ascertain
illness time course and treatment history. Through a
method similar to the LIFE technique [30], except for a
longer follow up period, the two psychiatrists produced
detailed life-charts accounting for the number and charac-
teristics of all affective episodes. These included age of
onset, DSM-IV type, severity (1 to 3, according to DSM-IV
classification), duration, drug used and dose, response to
treatment (0 = no response, 1 = partial, 2 = complete),
time of response, concomitant drugs and, for the intake
episode, occurrence in the postnatal period. Treatment
was coded using the Antidepressant Treatment History
Form (ATHF [31]). This is a scale ranging from 1 to 4
where a score of 1 corresponds to an administration of
any drug for less than 4 weeks or less than 100 mg of imi-
pramine equivalents, a score of 2 between 100 and 199
mg of imipramine equivalents for 4 weeks or more, a
score of 3 between 200 and 299 mg of imipramine equiv-
alents for 4 weeks or more and a score of 4 more than 300
mg imipramine equivalents. We included only those sub-
jects who scored 3 or more at the rating confidence scale
(RCS) of the Antidepressant Treatment History Form
(range 1–5, from no to high confidence level [31]).
Among predictive variables, drug maintenance played a
crucial role. A better outcome is observed with regular
maintenance. However the retrospective approach ham-
pers a complete assessment of this issue (e.g. stable com-
pliance, blood mood stabilizer levels). Maintenance was
performed with mood stabilizers at adequate doses for
prophylaxis and antidepressant scoring 2–4 on the ATHF
(1–4 for >60 years old patients). We scored this variableBMC Psychiatry 2006, 6:4 http://www.biomedcentral.com/1471-244X/6/4
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as maintenance absent (0) if maintenance was not taken
or if it was taken for less than one third of the disease
duration, present (2) if taken regularly for more than two
thirds of the illness length, partial (1) if taken between
one and two thirds and unknown if no or unreliable infor-
mation (ATHF-RCS <3) was available [6].
Family psychiatric history was collected throughout a
structured interview [32] and scored as follows: 0 = no
first or second degree relative affected by mood disorders;
1 = one to three second degree affected relatives; 2 = one
affected first degree relative or more than three second
degree affected relatives; 3 = more than one affected first
degree relative. All patients were evaluated on their life-
time symptomatology with the operational criteria
(OPCRIT) checklist [33]. This is a 90 item scale which cov-
ers most psychotic and affective disorder symptoms. It
was originally administered to identify the factor structure
of major psychoses [34-36], in the present paper it was
used to investigate psychotic features (delusions and/or
hallucinations).
Statistical analyses
Bipolar I and major depressive patients were analyzed sep-
arately. Per year rates of excited (manic + mixed) and
depressive episodes were compared between PPO and
NPPO mood disorders by means of Student's t test. Manic
and mixed episodes were pooled together since the retro-
spective nature of our investigation hampered a clear dis-
tinction between these two subtypes. In particular
psychotic mania could hardly be distinguished from a
delusional mixed state. Confounding variables – the list
included age of onset, length of illness, total number of
episodes, polarity of the intake episode, family history of
psychiatric disorders, psychotic features, comorbid per-
sonality disorders and treatment history – asymmetrically
distributed between PPO and NPPO samples (p < 0.05)
were controlled for using ANCOVA.
The power of our bipolar and MDD samples to detect dif-
ferences between PPO and NPPO groups was calculated
considering an alpha value of 0.01 two tailed. With these
parameters in each diagnostic sample we had a high
power (0.80) to detect a medium effect size (d = 0.80) that
corresponded to a difference of approximately 0.3 points
in the episode frequency (14% of variance explained)
between the two comparison groups [37]
Results
Bipolar sample
In the bipolar sample (N = 123) the mean age at illness
onset was 27.6 ± 7.3 years, at study entry it was 42.1 ± 13.5
years. Mean duration of illness was 14.5 ± 11.4 years; fam-
ily history of mood disturbance were reported in 92.% of
probands: 76% of them had one to three cases of affective
illness among their second degree relatives, the remaining
16% had more than three cases among their second
degree relatives or one affected first degree relative. Mood
episodes were on average 2.59 ± 2.07 for excited and 3.37
± 2.88 for depressive ones.
The characteristics of PPO and NPPO bipolar patients are
reported in table I. Women with postpartum onset disor-
ders significantly differed from non-postpartum controls
as they were more frequently married (p = 0.002), with a
lower recurrence of both excited (p = 0.005) and total
affective episodes (p = 0.005). Confounding variables
were all symmetrically distributed between comparison
groups, so they were not controlled by performing analy-
sis of covariance. One bipolar woman had a single epi-
Table 1: Comparison between postpartum and non-postpartum bipolar patients (N = 123)
Postpartum 
(N = 22)
Non-postpartum 
(N = 101)
Statistical Analyses
Age (years) 44.4 ± 12.4 41.7 ± 13.7 t = 0.89 p = 0.372
Marital status (Single/Married)1 1/21 36/60 X2 = 9.0 p = 0.002*
Education (years) 9.5 ± 3.0 10.4 ± 4.3 t = 1.16 p = 0.251
Workers for pay (Yes/No)2 9/13 56/39 X2 = 2.3 p = 0.125
Personality disorders (Yes/No)3 9/4 43/28 X2 = 0.3 p = 0.554
Age of onset (years) 27.2 ± 6.5 27.6 ± 7.5 t = 0.25 p = 0.800
Polarity at onset (excited/depressive) 5/17 35/66 X2 = 1.2 p = 0.279
Length of illness (years) 17.2 ± 11.2 13.9 ± 11.5 t = 1.22 p = 0.225
Familiarity (0 to 3) 1.00 ± 0.56 1.10 ± 0.85 t = 0.38 p = 0.379
Psychotic symptoms (Yes/No) 14/8 82/19 X2 = 3.2 p = 0.071
Maintenance (0 to 2) 0.95 ± 0.94 1.33 ± 0.91 t = 1.73 p = 0.086
Any polarity episodes (total number) 6.00 ± 3.6 5.96 ± 3.4 t = 0.05 p = 0.961
Any polarity episodes (number/year) 0.50 ± 0.34 0.81 ± 0.80 t = 2.85 p = 0.005*
Excited episodes (number/year) 0.21 ± 0.26 0.42 ± 0.45 t = 2.89 p = 0.005*
Depressive episodes (number/year) 0.29 ± 0.21 0.39 ± 0.51 t = 1.48 p = 0.141
*Significant p < 0.05. 1assessed in 118 patients; 2assessed in 117 patients; 3assessed in 84 patientsBMC Psychiatry 2006, 6:4 http://www.biomedcentral.com/1471-244X/6/4
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sode disorder. 7 out of 123 bipolar women (5.6%) met
criteria for rapid cycling disorder (see above): they were all
in the NPPO group.
Major depressive sample
Unipolar women (N = 150) mean age at illness onset was
29.4 ± 7.6 years, at study entry it was 48.6 ± 13.1 years.
Mean length of illness was 18.7 ± 13.2 years; family his-
tory of mood disturbance was reported in 83.% of
probands: 66% of them had one to three cases of affective
illness among their second degree relatives, the remaining
17% had more than three cases among their second
degree relatives or one affected first degree relative. An
average of 3.59 ± 3.27 mood disorder episodes were
observed in the sample.
The characteristics of PPO and NPPO major depressive
patients are reported in table 2. Compared to NPPO con-
trols, PPO patients were more frequently married (p =
0.004) and had a lower prevalence of comorbid personal-
ity disorders (p = 0.023). This latter feature was assessed
in 96 out of 150 patients (64%). In addition PPO patients
showed lower scores on the scale of maintenance treat-
ment (p = 0.002). With respect to illness course, PPO
patients had lower recurrence rates than their NPPO coun-
terpart (p = 0.016). This finding was no longer significant
after controlling for maintenance (ANCOVA: F = 1.31 p =
0.25).
27 major depressive women were diagnosed with single
episode disorder, 7 in the PPO (21%) and 20 in the NPPO
(17%) group (p = 0.59) Their mean length of illness was
12.7 ± 13.7 years compared to 17.3 ± 12.4 years of sub-
jects with recurrent episodes (p = 0.07). No major depres-
sive woman met criteria for rapid cycling disorder.
Discussion
This study addressed the topic of predicting the course of
mood disorders at early stages. For researchers, specific
time course predictors might help in identifying endophe-
notypes for biological and genetic investigations [38]. For
clinicians, the early recognition of disorders with a rela-
tively good prognosis would warrant less intensive treat-
ment and, as such, a minor burden of side effects.
Among possible early course predictors we focused on
postpartum onset because:
1) pregnancy and the postpartum period are distinct neu-
robiological states with regard to brain function and the
incidence of psychiatric disorders is different during these
periods [39,40];
2) to know how the disease may evolve is even more
important for a mother who has to take care of her child
in the early "critical" years of life.
Therefore we retrospectively evaluated illness course in
mood disorders with and without postpartum onset.
Since bipolar disorders have repeatedly been associated
with a poorer prognosis [3,41], bipolar and major
depressed patients were analyzed separately.
Bipolar sample
The most striking result was the lower recurrence of total
affective episodes and excited (manic/mixed) episodes in
PPO bipolar I disorder. In addition all bipolar women
with a rapid cycling disorder (7 out of 133) did not have
their intake episode during the postpartum period. Alto-
gether these findings suggest that in bipolar I disorder
postpartum onset may predict a time course characterized
by a lower recurrence. Whether this implies a better out-
come in terms of social functioning and quality of life was
an issue not addressed in the present study. We only
found that PPO bipolars were more frequently married
compared to NPPO comparison patients, while the two
groups were similar in education level and employment
status. Future research in this field should incorporate the
assessment of social adjustment and quality of life. On the
contrary, excited depressive episodes had a similar recur-
rence rate in PPO and NPPO bipolar disorders. A possible
explanation for this fact is based on recent evidence that
postpartum relapse in bipolar women is usually depres-
sive [42]. Another possible explanation is that in our PPO
group some bipolars might have an overall higher thresh-
old for relapse with the majority of episodes occurring
only in the postpartum period: such individuals are
expected to have fewer episodes during illness course,
almost exclusively depressive and in the postpartum
period. This would lead to a slight decrease in the rates of
depressive episodes but a significant decrease in manic
episodes. Such a hypothesis could not be verified here as
we had no information on postpartum episodes other
than the first one. Another explanation is that our findings
could be artefacts due to an asymmetric distribution of
established course predictors. Of such variables, anxiety
disorders [43,44], alcohol/substance abuse [45-47] and
inter-episode residual symptoms [48-50] were exclusion
criteria. Other confounding factors such as personality
disorders [15,51] and clinical features including age [52]
and polarity at onset [4,5,53], psychotic manifestations
[10,11], length of illness and number of episodes prior to
study entry [2,3,54] were similarly distributed between
PPO and NPPO samples. Drug maintenance was a crucial
issue in this study, although its effect is not clear. Lithium
prophylaxis in bipolar patients produces a significant
reduction of the mean number of episodes [55,56].
Unfortunately, even with sustained lithium prophylaxis,BMC Psychiatry 2006, 6:4 http://www.biomedcentral.com/1471-244X/6/4
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the likelihood of at least one recurrence exceeded 70%
within 5 years of recovery [57]. Moreover some have sug-
gested that antidepressant drugs may increase the recur-
rence rate in bipolars [58,59]. In our bipolar sample drug
maintenance could not bias results as it did not signifi-
cantly differ between PPO and NPPO subjects. However
there was no available information on patients' compli-
ance (e.g plasma levels of antidepressants [60] and mood
stabilizers [61]).
Depressive sample
Patients with PPO major depressive disorder experienced
fewer episodes during illness course compared to the
NPPO sample. The latter subjects were more likely to be
on maintenance treatment which could have lowered
their "natural" relapse rate. This strengthen the hypothesis
that PPO depressive disorder has a better course. However
the control for maintenance treatment greatly reduced the
difference between PPO and NPPO patients. It is a para-
doxical finding whose most likely implication is the lack
of a protective effect of maintenance therapy in our MDD
sample. It should be noted that PPO unipolar women
were also associated with a lower prevalence of personal-
ity disorders. This may (at least partially) explain why they
were less likely to relapse given the known negative
impact of axis II comorbidity on the outcome of mood
disorders [51]. The retrospective design of the study could
bias data collection toward a decreased detection of past
episodes and unreliable estimates of clinical variables. In
particular we found a very low prevalence of rapid cycling.
To control this bias we used a set of strategies: clinical
information was obtained by interviewing patients, their
relatives and previous health professionals and, whenever
possible, by examining records [29]; a blind experienced
psychiatrist reviewed charts; unreliability was assessed
and considered as exclusion criterion. Another caveat is
related to the atypical features of our sample collected in
a tertiary care setting. These are illustrated by the high per-
centage of bipolar disorders, the high rate of positive fam-
ily history and the fact that this value was not different
between BPD and MDD patients. Such flaws limit the gen-
eralizability of our results and emphasize the need for fur-
ther prospective studies.
Conclusion
Our preliminary data suggest that postpartum onset may
be associated with a less severe time course of mood dis-
orders. The present study design does not allow to suggest
postpartum affective disorder as a stand alone diagnostic
category. In fact an onset of the disease during the post-
partum period is not a good criterion to exclude "pseudo-
postpartum" patients, that is bipolar and major depressive
patients with episodes fortuitously occurring during post-
partum. Furthermore not all women in our control group
were parous, a prerequisite to understand their suscepti-
bility to postpartum recurrence.
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